BCHE and myasthenia gravis: Both AChE and BChE are crucial in the treatment of neurodegenerative disorders such as myasthenia gravis, Alzheimer and Parkinson’s disease, since so far the most successful approach in treating these disorders has been the use of cholinesterase inhibitors that target primary AChE [12, 13].